Sign In

Laura Furmanski

Partner and Head of Patient Square Insights at Patient Square Capital

Laura Furmanski is an accomplished professional with a proven track record in the healthcare investment sector. Currently associated with Patient Square Capital, a premier health care investment firm, Laura collaborates with top-tier management teams to enhance health through innovative products and technologies. Leveraging her expertise and a vast network, she contributes to the growth and success of companies in the healthcare industry.

Laura Furmanski's educational background includes a PhD in Cognitive Neuroscience from UCLA and a BA in Psychology from Stanford University. This strong academic foundation has equipped her with the knowledge and skills necessary to excel in the dynamic field of healthcare investments.

Throughout her career, Laura has held key positions in various organizations, showcasing her leadership abilities and strategic insights. She has served as a Board Member at prominent companies such as Elevage Medical Technologies, Resolve Biosciences, Radius Health, Inc., Enavate Sciences, and Apollo Therapeutics. Additionally, her roles as Partner and Head of Patient Square Insights at Patient Square Capital, Managing Director & Partner at The Boston Consulting Group (BCG), and SVP Bioinformatics at QIAGEN have further solidified her reputation as a seasoned professional.

Highlights

May 1 · linkedin

Excited to announce our newest partnership with Evan Melrose, MD, MBA and the launch of Elevage Medical Technologies as we aim to provide strategic support and capital to transformative medical device companies. Patient Square Capital will provide a $300 million capital commitment to support the development and launch of these transformative technologies. Read the full announcement here: https://lnkd.in/gsAyn46M #healthcare #medtech #privateequity

May 2 · linkedin

Extremely excited to announce our partnership with James Boylan and the launch of Enavate Sciences with the goal to provide capital and strategic support to therapeutic and enabling technology companies and to help address the current funding deficiencies in that market. Patient Square Capital will provide an initial $300 million commitment and we anticipate more funding over time. Read the full announcement here: https://lnkd.in/gfs-wMWG #healthcare #biotech #privateequity

Laura Furmanski
Add to my network

Location

Menlo Park, California, United States